المؤلفون: Djura Piersma, Marye J Boers-Sonderen, Geke A. P. Hospers, Karijn P M Suijkerbuijk, Christian U. Blank, Roos S. van Rijn, Astrid A M van der Veldt, Jan-Willem B de Groot, Ellen Kapiteijn, Franchette W P J van den Berkmortel, Alfonsus J. M. van den Eertwegh, Jesper van Breeschoten, Doranne L. Hilarius, Bert-Jan J. ten Tije, Michel W.J.M. Wouters, Art Vreugdenhil, John B. A. G. Haanen, Maureen J.B. Aarts, Willeke A. M. Blokx

المصدر: Br J Cancer

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cancer Research, business.industry, First line, Anti pd 1, Mutant, Correction, Cancer, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Medicine, business, Survival analysis, Advanced melanoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec07bf292a49af842f52b06a5d9be0e0Test
https://doi.org/10.1038/s41416-022-01772-zTest

المؤلفون: Alfonsus J. M. van den Eertwegh, Michel W.J.M. Wouters, Roos S. van Rijn, John B. A. G. Haanen, Maureen J.B. Aarts, Bert-Jan J. ten Tije, Karijn P M Suijkerbuijk, Christian U. Blank, Jesper van Breeschoten, Geke A. P. Hospers, Jan-Willem B de Groot, Franchette W P J van den Berkmortel, Ellen Kapiteijn, Doranne L. Hilarius, Marye J Boers-Sonderen, Djura Piersma, Art Vreugdenhil, Astrid A M van der Veldt, Willeke A. M. Blokx

المساهمون: VU University medical center, Obstetrics and gynaecology, Internal medicine, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, Radiology & Nuclear Medicine, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9)

المصدر: British Journal of Cancer
British Journal of Cancer, 124(7), 1222-1230. Nature Publishing Group
British Journal of Cancer, 124, 7, pp. 1222-1230
British Journal of Cancer, 124, 1222-1230
van Breeschoten, J, Wouters, M W J M, Hilarius, D L, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Blokx, W A M, Tije, B-J J T, Veldt, A A M V D, Vreugdenhil, A, Boers-Sonderen, M J & van den Eertwegh, A J M 2021, ' First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis ', British Journal of Cancer, vol. 124, no. 7, pp. 1222-1230 . https://doi.org/10.1038/s41416-020-01229-1Test
British Journal of Cancer, 124(7), 1222-1230. SPRINGERNATURE

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, PHASE-3, First line, Systemic therapy, VEMURAFENIB, Article, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], POOLED ANALYSIS, Matched cohort, SDG 3 - Good Health and Well-being, Internal medicine, Medicine, METASTATIC MELANOMA, neoplasms, Melanoma, Survival analysis, Advanced melanoma, nivolumab, business.industry, IPILIMUMAB, Anti pd 1, medicine.disease, DABRAFENIB, Propensity score matching, pembrolizumab, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::836391be4c5b8d33487fc86cac6f6337Test
https://doi.org/10.1038/s41416-020-01229-1Test

المؤلفون: Monique K, van der Kooij, Arjen, Joosse, Karijn P M, Suijkerbuijk, Maureen J B, Aarts, Franchette W P J, van den Berkmortel, Christian U, Blank, Marye J, Boers-Sonderen, Alfonsus J M, van den Eertwegh, Jan Willem B, de Groot, John B A G, Haanen, Geke A P, Hospers, Djura, Piersma, Rozemarijn S, van Rijn, Astrid A M, van der Veldt, Gerard, Vreugdenhil, Hans M, Westgeest, Michel W J M, Wouters, Olaf M, Dekkers, Ellen, Kapiteijn

المصدر: British journal of cancer.

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::6f5d2d254816a5181c6493297e5823f8Test
https://pubmed.ncbi.nlm.nih.gov/36564561Test

المؤلفون: Jesper, van Breeschoten, Michel W J M, Wouters, Doranne L, Hilarius, John B, Haanen, Christian U, Blank, Maureen J B, Aarts, Franchette W P J, van den Berkmortel, Jan-Willem B, de Groot, Geke A P, Hospers, Ellen, Kapiteijn, Djura, Piersma, Roos S, van Rijn, Karijn P M, Suijkerbuijk, Willeke A M, Blokx, Bert-Jan J Ten, Tije, Astrid A M van der, Veldt, Art, Vreugdenhil, Marye J, Boers-Sonderen, Alfonsus J M, van den Eertwegh

المصدر: Br J Cancer

مصطلحات موضوعية: Adult, Aged, 80 and over, Male, Proto-Oncogene Proteins B-raf, Programmed Cell Death 1 Receptor, MAP Kinase Kinase 1, Correction, Middle Aged, Prognosis, Survival Rate, Young Adult, Mutation, Humans, Female, Longitudinal Studies, Prospective Studies, Propensity Score, Melanoma, Protein Kinase Inhibitors, Aged, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::6fb24215d2be51efd09ee93525d7d7c6Test
https://pubmed.ncbi.nlm.nih.gov/35256756Test